Start with regulatory status
FDA-approved products undergo review for safety, effectiveness and quality for their approved uses. Compounded drugs are not FDA-approved; FDA does not review them in the same way before marketing. Their role depends on legal and individual clinical circumstances.
Ask for the actual preparation
Get the ingredient, route and dispensing pharmacy, and ask the licensed clinician why that particular preparation is being considered. Do not interpret a provider’s broad menu as evidence that every option is appropriate or legally available to every patient.
Compare costs only after clarity
A low quoted price does not establish clinical equivalence. Keep approved and compounded options visibly labeled in your notes. FDA’s current guidance is the primary reference for concerns about unapproved GLP-1 products.
Use these questions with a licensed clinician. Availability, suitability and price depend on your circumstances.
Explore the next stepSources & reading
FDA: concerns with unapproved GLP-1 drugsNIDDK: prescription medicines for weight managementProvider facts draw on official information checked October 12, 2026. See individual reviews for provider sources.